Value of B-type natriuretic peptide for identifying significantly elevated pulmonary artery wedge pressure in patients treated for established chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

This publication has 13 references indexed in Scilit:

• Plasma B-Type Natriuretic Peptide Levels in Ambulatory Patients With Established Chronic Symptomatic Systolic Heart Failure
  Circulation, 2003
• BNP in hormone-guided treatment of heart failure
  Trends in Endocrinology & Metabolism, 2002
• Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
  Circulation, 1999
• Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
  American Heart Journal, 1998
• Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end‐diastolic pressure
  Clinical Cardiology, 1993
• Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease.
  Heart, 1993
• Importance of hemodynamic response to therapy in predicting survival with ejection fraction ≤ 20% secondary to ischemic or nonischemic dilated cardiomyopathy
  The American Journal of Cardiology, 1990
• Relationship between plasma atrial natriuretic peptide concentration and atrial pressure in acute and chronic heart failure.
  Japanese Heart Journal, 1990
• Neurohumoral and hemodynamic changes in congestive heart failure: Lack of correlation and evidence of compensatory mechanisms
  American Heart Journal, 1988
• Atrial Natriuretic Peptide and Atrial Pressure in Patients with Congestive Heart Failure
  New England Journal of Medicine, 1986